Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-12

Clinical Trial Update: Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes? [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examines whether resveratrol can improve insulin sensitivity and preserve beta cell function after gestational diabetes, though …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: University of Manitoba | Conditions: Gestational Diabetes | Phase 4 | Status: UNKNOWN